Lymphoparietal index in esophageal cancer is stronger than tnm staging in long-term survival prognosis in a latin-american country

Figueroa-Giralt, Manuel; Valenzuela, Catalina; Torrealba, Andrés; Csendes, Attila; Braguetto, Italo; Lanzarini, Enrique; Musleh, Maher; Korn, Owen; Valladares, Hector; Cortés, Solange.
ABCD (São Paulo, Impr.) ; 33(3): e1547, 2020. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1152619

Documentos relacionados

  1. Comparison of clinicopathological features and prognostic significance between synchronous multiple primary and solitary esophageal squamous cell carcinomas.
  2. Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies.
  3. Patterns and prognostic predictive value of perineural invasion in esophageal squamous cell carcinoma.
  4. [Clinical characteristics of 272 437 patients with different histopathological subtypes of primary esophageal malignant tumors].
  5. A single-center prospective study evaluating the usefulness of artificial intelligence for the diagnosis of esophageal squamous cell carcinoma in a real-time setting.
  6. Prenylated PALM2 Promotes the Migration of Esophageal Squamous Cell Carcinoma Cells Through Activating Ezrin.
  7. Liquid biopsy of oesophageal squamous cell carcinoma: implications in diagnosis, prognosis, and treatment monitoring.
  8. Clinical Significance of Intramural Metastasis as an Independent Prognostic Factor in Esophageal Squamous Cell Carcinoma.
  9. Development and Validation of a New Staging System for Esophageal Squamous Cell Carcinoma Patients Based on Combined Pathological TNM, Radiomics, and Proteomics.
  10. Development and Validation of a Recurrence-Free Survival Prediction Model for Locally Advanced Esophageal Squamous Cell Carcinoma with Neoadjuvant Chemoradiotherapy.